UNIVERSITY OF ROCHESTER--CCOP RESEARCH BASE

罗切斯特大学癌症中心(URCC)，一家研究机构 在罗切斯特大学医学和牙科学院， 建议继续作为社区临床研究基地 肿瘤学计划(CCOP)申请机构。原创研究基地 自1983年以来，URCC CCOP研究基地一直在为CCOP计划服务 为癌症控制研究提供了相当多的资源 活动。 这种相互竞争的更新集中在发展和 临床癌症控制研究的实施 癌症研究基地专供癌症控制研究。 城市资源中心研究基地致力于促进 通过成员CCOP和 附属公司，我们研究基地经验丰富的癌症控制专家，以及 癌症控制领域的顾问。这项技术的初步成功是 事实表明，超过一半(10/18)的CCOP和 与我们合作超过两年的附属公司提出了一项 已提交给NCI的概念。CCOP成员和附属公司拥有 提出了14个癌症控制概念，其中5个已经开发出来 转换成协议。此外，六项现任或前任议定书担任主席。 由CCOP成员或附属公司提供。 在过去的五年中，2,573名患者(相当于876.0学分) 已经注册过了。市建中心研究基地开设了八个癌症控制中心 方案并关闭了五个癌症控制方案，同时总共提供了 21个常规方案和6个基于少数族裔的CCOP方案。目前有 在五个积极的癌症控制方案中积累了18个CCOP患者 城市交通协调中心网络。

The University of Rochester Cancer Center (URCC), a research institute within the University of Rochester School of Medicine and Dentistry, proposes to continue serving as a Research Base for Community Clinical Oncology Program (CCOP) applicant institutions. An original Research Base serving the CCOP program since 1983, the URCC CCOP Research Base has evolved and developed considerable resources for cancer control research activities. This competing renewal focuses on strengths in the development and implementation of cancer control studies resulting from being a clinical cancer research base exclusively for cancer control research. The URCC Research Base is committed to a process and climate that fosters protocol development through collaboration among member CCOPs and affiliates, experienced cancer control experts at our Research Base, and consultants in cancer control areas. The beginning success of this is shown through the fact that over half (10 of 18) of our CCOPs and affiliates who have been with us for more than two years have proposed a concept that has been submitted to NCI. CCOP members and affiliates have proposed 14 cancer control concepts, five of which have been developed into protocols. Furthermore, six current or former protocols are chaired by CCOP members or affiliates. Over the past five years, 2573 patients (representing 876.0 credits) have been registered. The URCC Research Base has opened eight cancer control protocols and closed five cancer control protocols while serving a total of 21 regular and six minority based CCOP programs. There are currently 18 CCOPs accruing patients on five active cancer control protocols within the URCC network.